Control fibroblasts | IPF fibroblasts | |||
---|---|---|---|---|
n | n | |||
Figure 1D | ||||
PPARα/GAPDH | 1 ± 0.38 | 4 | 1.5 ± 0.10 | 5 |
PPARβ/GAPDH | 1 ± 0.26 | 5 | 0.8 ± 0.05 | 4 |
PPARγ/GAPDH | 1 ± 0.75 | 5 | 1.4 ± 0.60 | 5 |
Figure 2C, D | ||||
COL1/GAPDH | ||||
TGFβ − | 1 ± 0.44 | 6 | 0.7 ± 0.52 | 6 |
TGFβ + | 2.4 ± 0.74 | 6 | 1.6 ± 0.76 | 6 |
α-SMA/GAPDH | ||||
TGFβ − | 1 ± 0.36 | 6 | 0.9 ± 0.31 | 6 |
TGFβ + | 1.5 ± 0.16 | 6 | 1.3 ± 0.44 | 6 |
Figure 6C | ||||
CAT/β-ACTIN | 1 ± 0.63 | 5 | 0.3 ± 0.29 | 5 |
Figure S1C | ||||
α-SMA/β-ACTIN | 1 ± 0.13 | 5 | 0.7 ± 0.46 | 7 |
COL1/β-ACTIN | 1 ± 0.54 | 5 | 0.5 ± 0.62 | 7 |
TGFBR1/β-ACTIN | 1 ± 0.47 | 5 | 0.3 ± 0.42 | 7 |
MMP-1/β-ACTIN | 1 ± 0.72 | 5 | 1.4 ± 1.12 | 7 |